{"id":"https://openalex.org/W1877400101","doi":null,"title":"Role of the bisphosphonate etidronate in the therapy of cancer-related hypercalcemia.","display_name":"Role of the bisphosphonate etidronate in the therapy of cancer-related hypercalcemia.","alternate_titles":[],"publication_year":1990,"publication_date":"1990-04-01","ids":{"openalex":"https://openalex.org/W1877400101","mag":"1877400101","pmid":"https://pubmed.ncbi.nlm.nih.gov/2110387"},"language":"en","primary_location":{"id":"pmid:2110387","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/2110387","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Seminars in oncology","raw_type":"Journal Article"},"parent_works":[],"lineage":["https://openalex.org/W1877400101"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5112779134","display_name":"Frederick R. Singer","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1282927834","display_name":"Cedars-Sinai Medical Center","ror":"https://ror.org/02pammg90","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1282927834"]}],"countries":["US"],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"F R Singer","raw_affiliation_strings":["Bone Center, Cedars-Sinai Medical Center, Los Angeles, CA 90048"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Bone Center, Cedars-Sinai Medical Center, Los Angeles, CA 90048","institution_ids":["https://openalex.org/I1282927834"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5112779134"],"corresponding_institution_ids":["https://openalex.org/I1282927834"],"apc_list":null,"apc_paid":null,"fwci":1.178,"has_fulltext":false,"cited_by_count":15,"citation_normalized_percentile":{"value":0.80125469,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":87,"max":92},"biblio":{"volume":"17","issue":"2 Suppl 5","first_page":"34","last_page":"39"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11221","display_name":"Bone health and treatments","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11221","display_name":"Bone health and treatments","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10516","display_name":"Parathyroid Disorders and Treatments","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2727","display_name":"Nephrology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10071","display_name":"Bone health and osteoporosis research","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2732","display_name":"Orthopedics and Sports Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/etidronate","display_name":"etidronate","score":0.9860000014305115},{"id":"https://openalex.org/keywords/bisphosphonates","display_name":"bisphosphonates","score":0.9980000257492065},{"id":"https://openalex.org/keywords/cancer-related-hypercalcemia","display_name":"cancer-related hypercalcemia","score":0.9649999737739563},{"id":"https://openalex.org/keywords/hypercalcemia-of-malignancy","display_name":"hypercalcemia of malignancy","score":0.9599999785423279},{"id":"https://openalex.org/keywords/osteoclastic-bone-resorption","display_name":"osteoclast resorption","score":0.8130000233650208},{"id":"https://openalex.org/keywords/calcitonin","display_name":"calcitonin","score":0.7300000190734863},{"id":"https://openalex.org/keywords/intravenous-infusion","display_name":"intravenous infusion","score":0.6449999809265137},{"id":"https://openalex.org/keywords/drug-toxicity","display_name":"drug toxicity","score":0.6460000276565552},{"id":"https://openalex.org/keywords/chemotherapy-tolerance","display_name":"chemotherapy tolerance","score":0.5979999899864197},{"id":"https://openalex.org/keywords/antibiotic-administration","display_name":"antibiotic administration","score":0.5379999876022339}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9661320447921753},{"id":"https://openalex.org/C2777251235","wikidata":"https://www.wikidata.org/wiki/Q412205","display_name":"Bisphosphonate","level":3,"score":0.7498297691345215},{"id":"https://openalex.org/C673006","wikidata":"https://www.wikidata.org/wiki/Q4941581","display_name":"Bone resorption","level":2,"score":0.5893669724464417},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.5655895471572876},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.5436933636665344},{"id":"https://openalex.org/C2779627488","wikidata":"https://www.wikidata.org/wiki/Q315860","display_name":"Calcitonin","level":2,"score":0.5345133543014526},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.46122270822525024},{"id":"https://openalex.org/C29730261","wikidata":"https://www.wikidata.org/wiki/Q274160","display_name":"Toxicity","level":2,"score":0.45790669322013855},{"id":"https://openalex.org/C2776541429","wikidata":"https://www.wikidata.org/wiki/Q165328","display_name":"Osteoporosis","level":2,"score":0.45757222175598145},{"id":"https://openalex.org/C2908539429","wikidata":"https://www.wikidata.org/wiki/Q412205","display_name":"Diphosphonates","level":3,"score":0.44478732347488403},{"id":"https://openalex.org/C2781104859","wikidata":"https://www.wikidata.org/wiki/Q2758338","display_name":"Etidronic acid","level":3,"score":0.4326578974723816},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.42503249645233154}],"mesh":[{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006934","descriptor_name":"Hypercalcemia","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D006934","descriptor_name":"Hypercalcemia","qualifier_ui":"Q000209","qualifier_name":"etiology","is_major_topic":false},{"descriptor_ui":"D009369","descriptor_name":"Neoplasms","qualifier_ui":"Q000150","qualifier_name":"complications","is_major_topic":true},{"descriptor_ui":"D012968","descriptor_name":"Etidronic Acid","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D012968","descriptor_name":"Etidronic Acid","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D015394","descriptor_name":"Molecular Structure","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"pmid:2110387","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/2110387","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Seminars in oncology","raw_type":"Journal Article"},{"id":"mag:1877400101","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/2110387","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"PubMed","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":1.0,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":14,"referenced_works":["https://openalex.org/W48842805","https://openalex.org/W1968592904","https://openalex.org/W1974903174","https://openalex.org/W1988298562","https://openalex.org/W2004672175","https://openalex.org/W2018777439","https://openalex.org/W2029483636","https://openalex.org/W2037935981","https://openalex.org/W2042020890","https://openalex.org/W2054887634","https://openalex.org/W2066694610","https://openalex.org/W2077653472","https://openalex.org/W2083258979","https://openalex.org/W2086591058"],"related_works":["https://openalex.org/W2330624361","https://openalex.org/W2409621768","https://openalex.org/W2072764667","https://openalex.org/W1970284797","https://openalex.org/W2028138621","https://openalex.org/W2029483636","https://openalex.org/W2086591058","https://openalex.org/W2085584720","https://openalex.org/W62888693","https://openalex.org/W1987868778"],"abstract_inverted_index":{"Bisphosphonates":[0],"(formerly":[1],"diphosphonates),":[2],"analogues":[3],"of":[4,10,18,36,51,68,96,118,130,144,162,173],"endogenous":[5],"pyrophosphates,":[6],"are":[7],"potent":[8],"inhibitors":[9],"osteoclastic":[11],"bone":[12],"resorption.":[13],"While":[14],"the":[15,24,30,34,39,46,113,152,171],"exact":[16],"mechanism":[17],"action":[19],"remains":[20],"poorly":[21],"understood,":[22],"etidronate,":[23],"only":[25],"bisphosphonate":[26],"currently":[27],"available":[28],"in":[29,71,151],"United":[31],"States":[32],"for":[33],"treatment":[35],"hypercalcemia,":[37],"decreases":[38],"elevated":[40],"serum":[41],"calcium":[42],"levels":[43],"and":[44,55,122,139,146,169],"alleviates":[45],"symptoms":[47],"associated":[48],"with":[49,154],"hypercalcemia":[50,156],"malignancy.":[52],"Both":[53],"open":[54],"controlled":[56],"clinical":[57],"studies":[58],"have":[59],"demonstrated":[60],"that":[61,134],"this":[62,131,174],"agent,":[63],"administered":[64,100],"at":[65],"a":[66,83],"dose":[67],"7.5":[69],"mg/kg/d":[70],"2-hour":[72],"intravenous":[73],"infusions":[74],"over":[75],"3":[76],"to":[77,89,92,101,159],"7":[78],"days,":[79],"promotes":[80],"normocalcemia.":[81],"In":[82],"randomized":[84],"study,":[85],"etidronate":[86],"was":[87],"shown":[88],"be":[90],"superior":[91],"maximally":[93],"approved":[94],"doses":[95],"calcitonin.":[97],"Moreover,":[98],"when":[99],"patients":[102],"without":[103],"overt":[104],"renal":[105],"failure":[106],"(serum":[107],"creatinine":[108],"less":[109],"than":[110],"2.5":[111],"mg/dL),":[112],"drug":[114],"is":[115,133,157],"remarkably":[116],"free":[117],"significant":[119],"acute":[120],"toxicity":[121],"side":[123],"effects.":[124],"Therefore,":[125],"an":[126],"important":[127],"therapeutic":[128],"aspect":[129],"agent":[132],"it":[135],"permits":[136],"concurrent":[137],"antibiotic":[138],"chemotherapy":[140],"administration.":[141],"Judicious":[142],"use":[143],"appropriate":[145],"specific":[147],"pharmacologic":[148],"intervention":[149],"strategies":[150],"patient":[153],"cancer-related":[155],"expected":[158],"enhance":[160],"quality":[161],"life,":[163],"improve":[164],"systemic":[165],"cancer":[166],"therapy":[167],"tolerance,":[168],"reduce":[170],"morbidity":[172],"serious":[175],"neoplastic":[176],"complication.":[177]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W1877400101","counts_by_year":[{"year":2025,"cited_by_count":1}],"updated_date":"2026-11-16T12:05:36.265796","created_date":"2016-06-24T00:00:00"}
